|
|
CDC NIP/NIC Home Page
|
Grand Salon E
| |||
J3: The Time is Now: Preparing for the Next Generation of Pneumococcal Vaccines | |||
| Pneumococcal conjugate vaccine has dramatically reduced the incidence of pneumococcal disease in the U.S., not only among children targeted for vaccination but also among those too young or too old to receive the vaccine. In the near future, new pneumococcal vaccines are likely to be available for children and, possibly, for adults. This workshop will emphasize the current state of evaluating pneumococcal vaccine impact, including local, state, and national perspectives. Novel strategies for assessing vaccine impact and state-based immunization programs will be reviewed with an eye toward preparing for the introduction and assessment of new pneumococcal vaccines. | |||
| Moderator: | Matthew Moore | ||
| 4:00 PM | Introductory Remarks | ||
| 4:05 PM | 97 | Pneumococcal Disease Mortality in the United States, 1990-2004 Marifi Pulido, Frank Sorvillo, A. Nelson El-Amin, Dulmini Kodagoda | |
| 4:20 PM | 98 | Evaluation of national reporting of invasive pneumococcal disease (IPD) Meredith Deutscher, Adam Cohen, Matthew R. Moore, Sandra Roush, Pekka Nuorti | |
| 4:35 PM | 99 | Invasive Streptococcus pneumoniae (IPD) Serotype Project, Children Under Five, Oklahoma Jolianne P. Stone, Lauri Smithee, Kristy Bradley, McDermott Michael | |
| 4:50 PM | Discussion | ||